Dynavax Technologies | Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
AbbVie USD 3.89B 325M 2025-12
Adma Biologics USD 23.05M 320K 2025-09
Agenus USD 23.6M 448K 2025-09
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Dynavax Technologies USD 40.09M 1.45M 2025-09
Gilead Sciences USD 1.78B 425M 2025-12
Glaxosmithkline GBP 2.91B 817.89M 2025-09
Merck USD 2.85B 215M 2025-12
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Novartis USD 3.31B 134M 2025-09
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
TG Therapeutics USD 63.37M 51.33M 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


Dynavax Technologies Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.